Eribulin Mesylate in Combination With Intermittent Erlotinib in Patients With Previously Treated, Advanced Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung CancerInterventions: Drug: eribulin mesylate + erlotinib; Drug: eribulin mesylate + erlotinibSponsor: Eisai Inc.Recruiting - verified May 2010






